EP 1883412 A4 20080903 - COMBINATION THERAPY WITH SULODEXIDE AND A BLOOD PRESSURE REDUCING AGENT IN THE TREATMENT OF DIABETIC NEPHROPATHY
Title (en)
COMBINATION THERAPY WITH SULODEXIDE AND A BLOOD PRESSURE REDUCING AGENT IN THE TREATMENT OF DIABETIC NEPHROPATHY
Title (de)
KOMBINATIONSTHERAPIE MIT SULODEXID UND EINEM BLUTDRUCKSENKENDEN MITTEL BEI DER BEHANDLUNG VON DIABETISCHER NEPHROPATHY
Title (fr)
THERAPIE COMBINEE AVEC LE SULODEXIDE ET UN AGENT DE REDUCTION DE LA PRESSION SANGUINE DANS LE TRAITEMENT DE LA NEPHROPATHIE DIABETIQUE
Publication
Application
Priority
- US 2006017403 W 20060505
- US 67909605 P 20050505
- US 73697305 P 20051114
Abstract (en)
[origin: WO2006121853A1] The present invention is directed to a method of treating patients suffering from nephropathy of diabetic origin by administration of sulodexide in combination with a blood pressure reducing agent, such as an inhibitor of an angiotensin converting enzyme (ACE inhibitor) and/or with an angiotensin II receptor blocker (ARB). The effectiveness of sulodexide with an ACE inhibitor or an ARB has been shown by the significant decrease of the albuminuria in microalbuminuric diabetic patients.
IPC 8 full level
A61K 31/737 (2006.01); A61K 31/40 (2006.01); A61K 31/41 (2006.01); A61K 31/727 (2006.01); A61K 45/06 (2006.01); A61P 13/12 (2006.01)
CPC (source: EP)
A61K 31/40 (2013.01); A61K 31/41 (2013.01); A61K 31/727 (2013.01); A61K 31/728 (2013.01); A61K 31/737 (2013.01); A61K 45/06 (2013.01); A61P 3/10 (2017.12); A61P 13/12 (2017.12); A61P 43/00 (2017.12)
Citation (search report)
- [X] WO 0193850 A2 20011213 - ALFA WASSERMANN INC [US], et al
- [X] GAMBARO GIOVANNI ET AL: "Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type 1 and type 2 diabetic patients: The Di.N.A.S. randomized trial", JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, vol. 13, no. 6, June 2002 (2002-06-01), pages 1615 - 1625, XP002486358, ISSN: 1046-6673
- [X] CANDIDO RICCARDO ET AL: "Treatment for diabetic nephropathy - a review of the recent patent literature.", IDRUGS : THE INVESTIGATIONAL DRUGS JOURNAL MAR 2002, vol. 5, no. 3, March 2002 (2002-03-01), pages 237 - 265, XP002486359, ISSN: 1369-7056
- See references of WO 2006121853A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR MK YU
DOCDB simple family (publication)
WO 2006121853 A1 20061116; AU 2006244446 A1 20061116; CA 2606880 A1 20061116; EP 1883412 A1 20080206; EP 1883412 A4 20080903; IL 187142 A0 20080605; JP 2008540448 A 20081120
DOCDB simple family (application)
US 2006017403 W 20060505; AU 2006244446 A 20060505; CA 2606880 A 20060505; EP 06759150 A 20060505; IL 18714207 A 20071104; JP 2008510255 A 20060505